Anika Therapeutics (ANIK) Q1 2025 Earnings

12MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.25
-0.11
0.03
0.17

Details

Expected EPS
-0.225
Actual EPS
-0.03
Surprise EPS
0.2
Surprise Percent
+86.67%

Description

Anika Therapeutics (ANIK) has reported earnings of -0.03 per share for Q1 2025.

0 Comments

Share your thoughts